Lead-inhibited adenylate cyclase: a model for the evaluation of chelating agents in the treatment of cns lead toxicity
- 1 September 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 29 (1) , 511-513
- https://doi.org/10.1111/j.2042-7158.1977.tb11384.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Cyclic nucleotides and nervous system function.Physiological Reviews, 1977
- Meso-dimercaptosuccinic acid a chelating agent for the treatment of mercury and lead poisoningJournal of Pharmacy and Pharmacology, 1976
- Lead Poisoning: Altered Urinary Catecholamine Metabolites as Indicators of Intoxication in Mice and ChildrenScience, 1976
- Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters†Nature, 1976
- Pharmacological and neurochemical investigations of lead-induced hyperactivityNeuropharmacology, 1975
- Lead-induced inhibition of brain adenyl cyclaseNature, 1975
- The use of chelating agents in the treatment of acute and chronic lead intoxication in childhoodThe Journal of Pediatrics, 1968
- Adenyl CyclasePublished by Elsevier ,1962
- ADENYL CYCLASE .4. EFFECTS OF NEUROHORMONES ON FORMATION OF ADENOSINE 3',5'-PHOSPHATE BY PREPARATIONS FROM BRAIN AND OTHER TISSUES1962
- THE TREATMENT OF METAL POISONING WITH PENICILLAMINEThe Lancet, 1957